ストックスクリーナーアプリを入手
1.06
6.92%
0.0686
前日終値:
$0.9914
開ける：
$1
24時間の取引高:
173.04K
Relative Volume:
1.62
時価総額：
$46.86M
収益：
$15.97M
当期純損益:
$-24.40M
株価収益率:
-1.3975
EPS:
-0.7585
ネットキャッシュフロー:
$-45.82M
1週間 パフォーマンス:
+10.81%
1か月 パフォーマンス:
-3.64%
6か月 パフォーマンス:
+95.32%
1年 パフォーマンス:
-40.78%
1日の値動き範囲:
$1.00
$1.06
1週間の範囲:
$0.93
$1.06
52週間の値動き範囲:
$0.50
$2.64
Elutia Inc Stock (ELUT) Company Profile
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.06 | 46.86M | 15.97M | -24.40M | -45.82M | -0.7585 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 開始されました | Cowen | Outperform |
| 2020-11-02 | 開始されました | Piper Sandler | Overweight |
| 2020-11-02 | 開始されました | Truist | Buy |
Elutia Inc (ELUT) 最新ニュース
Elutia Inc (ELUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Elutia Inc (ELUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elutia Inc (ELUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elutia Inc (ELUT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elutia Inc (ELUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elutia Inc (ELUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Elutia Inc (ELUT) Institutional Confidence - TradingKey
Elutia Inc (ELUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Elutia Inc (ELUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
ELUT: Drug-eluting biologic for breast reconstruction targets high infection rates in a $1.5B market - TradingView
Elutia Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesBanking Earnings Report - newsline.com
Elutia shareholders approve board proposals at annual meeting - Investing.com
Elutia shareholders approve board proposals at annual meeting By Investing.com - Investing.com Nigeria
Elutia Shareholders Approve Amended Incentive Plan and Governance - TipRanks
Elutia (ELUT) investors approve equity plan amendment and annual say-on-pay - Stock Titan
Elutia Inc. (ELUT) Q1 2026 Earnings: EPS Misses Estimates as Company Navigates Early-Stage PipelineRevenue Warning Signal - newsline.com
Elutia (ELUT) grants director Kevin Rakin 159,590 stock options - Stock Titan
Elutia (NASDAQ: ELUT) director awarded 106K stock options as compensation - Stock Titan
Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike - Stock Titan
Elutia (NASDAQ: ELUT) director Brigid Makes receives 106,393-share stock option grant - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Ticks UpNext Quarter Guidance - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Edges Higher Despite SurpriseShare Dilution Risk - newsline.com
ELUTIA (ELUT) CSO reports RSU vesting and tax withholding share disposition - Stock Titan
Elutia (ELUT) CFO reports RSU vesting and tax withholding event - Stock Titan
Elutia (ELUT) CEO RSUs vest; shares withheld to cover taxes - Stock Titan
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th - BioSpace
Breast reconstruction infections: Elutia to outline biomatrix tech in Vegas - Stock Titan
Elutia Inc. (ELUT) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesMargin Guidance - newsline.com
Elutia Inc. (ELUT) Edges Higher: Approaching Resistance Amid Low-Volume RallyRectangle Pattern - newsline.com
Elutia Inc. (ELUT) Edges Higher: Stock Gains 3.49% as Price Approaches Key ResistanceEqual Weight ETF - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Moves HigherHigh Estimate Range - newsline.com
Elutia Inc. (ELUT) Slips Nearly 5% as Stock Tests Key Support LevelsDescending Triangle - newsline.com
Elutia Inc. (ELUT) Shows Signs of Weakening Momentum Near Support LevelsOrder Block - newsline.com
Despite Elutia's Pullback, Insiders Still Gained US$75k - simplywall.st
Elutia (ELUT) director gifts shares and updates trust, HighCape stakes - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Nearly 7%Profit Announcement - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates on Higher Operating CostsDownward Estimate Revision - newsline.com
Elutia Inc. (ELUT) Holds Near Key Support After Marginal DeclineChannel Projection - newsline.com
Elutia Stock Flat Ahead of Open as $1.5 Billion Decision Waits - Bez Kabli
Elutia Inc. (ELUT) Slips 3.33% as Stock Tests Key Support LevelsStop Run - The Legal Advocate
Elutia Inc. (ELUT) Dips 3.33% as Stock Hovers Near Critical $1.10 SupportRevenue Growth Stocks - Newser
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching - GlobeNewswire
Elutia (ELUT) Q1 2026 Earnings Miss by Significant: Key TakeawaysEarnings Seasonality - thelegaladvocate.com
Elutia (ELUT) Q1 2026 Results: Profit Pressure, Guidance CutPost-Earnings Reaction - Newser
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Sahm
Elutia (ELUT) Q1 2026 Earnings Miss: EPS $-0.17 vs $-0.15 ExpectedDownward Estimate Revision - The Legal Advocate
ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1.5B market - TradingView
Elutia Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Is Elutia (ELUT) Overvalued After Q1 2026? EPS Not Disclosed; Re - GuruFocus
Elutia (ELUT) Q1 2026 Earnings Transcript - AOL.com
Elutia (NASDAQ: ELUT) posts wider Q1 2026 loss while holding $28.5M cash - Stock Titan
Elutia Inc (ELUT) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
大文字化:
|
ボリューム (24 時間):